SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech - Quaterly Results

12 Feb 2024 Evaluate
The Turnover for the quarter ended December 2023 of Rs. 893.51 millions increase by 66.23% from Rs. 537.53 millions.The Total Profit for the quarter ended December 2023 of Rs. 116.97 millions grew from Rs.-580.62 millions Operating profit Margin for the quarter ended December 2023 improved to 290.71% as compared to -52.15% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 893.51 537.53 66.23 2174.35 2283.29 -4.77 3289.20 3879.61 -15.22
Other Income 25.77 9.00 186.33 66.57 73.93 -9.96 75.60 75.26 0.45
PBIDT 290.71 -52.15 -657.45 347.18 204.81 69.51 463.57 834.63 -44.46
Interest 51.64 51.45 0.37 136.37 144.93 -5.91 209.42 172.26 21.57
PBDT 239.07 -549.49 -143.51 120.81 -386.01 -131.30 -341.74 662.37 -151.59
Depreciation 61.27 61.56 -0.47 174.96 186.01 -5.94 245.14 236.74 3.55
PBT 177.80 -611.05 -129.10 -54.15 -572.02 -90.53 -586.88 425.63 -237.89
TAX 60.83 -30.43 -299.90 60.83 -23.06 -363.79 -11.55 123.25 -109.37
Deferred Tax 0.00 0.00 0.00 0.00 -0.03 0.00 0.00 49.18 0.00
PAT 116.97 -580.62 -120.15 -114.98 -548.96 -79.05 -575.33 302.38 -290.27
Equity 144.37 144.29 0.06 144.37 144.29 0.06 144.29 144.24 0.03
PBIDTM(%) 32.54 -9.70 -435.36 15.97 8.97 78.01 14.09 21.51 -34.49

Fermenta Biotech Share Price

312.55 -9.30 (-2.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×